You just read:

CytoSorb® Removal of Ticagrelor Intraoperatively Results in Projected Cost Savings of Approximately $5,000 in Each Patient Undergoing Emergency Cardiac Surgery

News provided by

CytoSorbents Corporation

Oct 04, 2019, 07:08 ET